STIM: שווי שוק לרווח נקי מותאם קצב צמיחה neurostar.com
Neuronetics, Inc. (STIM) develops specialized systems for treating depression. The PEG ratio allows for a valuation of Neuronetics, Inc. (STIM), where 0.00 represents the latest metric reading. Revenues rely on physician recognition of magnetic stimulation efficacy and insurance coverage. Device assembly is handled internally, with electronics sourced from external partners. The mature NeuroStar product line serves as a modern non-invasive solution.
Neuronetics, Inc. (STIM) - פילוחי מדדים ודוחות פיננסיים
As a manufacturer of neurostimulation systems, Neuronetics, Inc. (STIM) faces risks associated with slow market adoption of its technologies and competition from pharmacological treatments. The PEG ratio compares market valuation with earnings growth, identifying an undervalued asset when the value falls below one. Analyzing this chart helps determine whether the business's expansion potential offsets current challenges regarding insurance reimbursement.
